Immunizing teenagers is a critical part of slowing the pandemic and reaching herd immunity. But enrolling them in clinical trials poses challenges that are very different than wrangling adults.
from NYT > Health https://ift.tt/2Nbuhyw
via health&fitness
Aucun commentaire:
Enregistrer un commentaire